News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
851,658 Results
Type
Article (86770)
Company Profile (704)
Press Release (764182)
Multimedia
Podcasts (141)
Webinars (18)
Section
Business (232782)
Career Advice (4131)
Deals (39751)
Drug Delivery (129)
Drug Development (91075)
Employer Resources (198)
FDA (18164)
Job Trends (17357)
News (396740)
Policy (39804)
Tag
Academia (3002)
Academic (2)
Accelerated approval (9)
Adcomms (32)
Allergies (104)
Alliances (56957)
ALS (115)
Alzheimer's disease (1545)
Antibody-drug conjugate (ADC) (186)
Approvals (18115)
Artificial intelligence (382)
Autoimmune disease (35)
Automation (18)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (127)
Biotechnology (481)
Bladder cancer (95)
Brain cancer (38)
Breast cancer (381)
Cancer (2973)
Cardiovascular disease (238)
Career advice (3538)
Career pathing (34)
CAR-T (201)
CDC (38)
Cell therapy (555)
Cervical cancer (24)
Clinical research (74120)
Collaboration (1065)
Company closure (3)
Compensation (662)
Complete response letters (30)
COVID-19 (2895)
CRISPR (64)
C-suite (324)
Cystic fibrosis (117)
Data (2930)
Decentralized trials (2)
Denatured (49)
Depression (67)
Diabetes (370)
Diagnostics (6968)
Digital health (26)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (172)
Drug pricing (149)
Drug shortages (35)
Duchenne muscular dystrophy (126)
Earnings (97428)
Editorial (48)
Employer branding (25)
Employer resources (168)
Events (131337)
Executive appointments (897)
FDA (19814)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (981)
Gene editing (142)
Generative AI (37)
Gene therapy (423)
GLP-1 (918)
Government (5240)
Grass and pollen (6)
Guidances (180)
Healthcare (20915)
Huntington's disease (31)
IgA nephropathy (41)
Immunology and inflammation (174)
Immuno-oncology (9)
Indications (39)
Infectious disease (3076)
Inflammatory bowel disease (163)
Inflation Reduction Act (13)
Influenza (66)
Intellectual property (119)
Interviews (813)
IPO (17892)
IRA (55)
Job creations (5192)
Job search strategy (2861)
Kidney cancer (15)
Labor market (54)
Layoffs (584)
Leadership (26)
Legal (10131)
Liver cancer (84)
Lung cancer (422)
Lymphoma (206)
Machine learning (9)
Management (65)
Manufacturing (417)
MASH (92)
Medical device (14702)
Medtech (14707)
Mergers & acquisitions (22544)
Metabolic disorders (935)
Multiple sclerosis (103)
NASH (23)
Neurodegenerative disease (137)
Neuropsychiatric disorders (39)
Neuroscience (2268)
NextGen: Class of 2025 (7687)
Non-profit (5089)
Now hiring (48)
Obesity (482)
Opinion (288)
Ovarian cancer (98)
Pain (115)
Pancreatic cancer (117)
Parkinson's disease (196)
Partnered (25)
Patents (303)
Patient recruitment (150)
Peanut (54)
People (65636)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22881)
Phase II (32184)
Phase III (24234)
Pipeline (1619)
Policy (231)
Postmarket research (3552)
Preclinical (10333)
Press Release (72)
Prostate cancer (142)
Psychedelics (40)
Radiopharmaceuticals (277)
Rare diseases (502)
Real estate (7399)
Recruiting (75)
Regulatory (27055)
Reports (61)
Research institute (2663)
Resumes & cover letters (650)
Rett syndrome (9)
RNA editing (9)
RSV (54)
Schizophrenia (92)
Series A (165)
Series B (109)
Service/supplier (30)
Sickle cell disease (64)
Special edition (22)
Spinal muscular atrophy (167)
Sponsored (36)
Startups (4300)
State (2)
Stomach cancer (16)
Supply chain (81)
Tariffs (63)
The Weekly (90)
Vaccines (887)
Venture capital (54)
Weight loss (326)
Women's health (48)
Worklife (20)
Date
Today (150)
Last 7 days (572)
Last 30 days (2679)
Last 365 days (34191)
2025 (17197)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (70)
Alaska (7)
Arizona (280)
Arkansas (14)
Asia (50460)
Australia (8872)
California (7573)
Canada (2323)
China (698)
Colorado (326)
Connecticut (342)
Delaware (198)
Europe (115774)
Florida (1117)
Georgia (258)
Hawaii (2)
Idaho (65)
Illinois (725)
India (32)
Indiana (382)
Iowa (18)
Japan (224)
Kansas (115)
Kentucky (32)
Louisiana (17)
Maine (73)
Maryland (1081)
Massachusetts (5790)
Michigan (273)
Minnesota (474)
Mississippi (3)
Missouri (97)
Montana (32)
Nebraska (26)
Nevada (80)
New Hampshire (73)
New Jersey (2116)
New Mexico (31)
New York (2133)
North Carolina (1220)
North Dakota (10)
Northern California (3261)
Ohio (245)
Oklahoma (16)
Oregon (48)
Pennsylvania (1623)
Puerto Rico (18)
Rhode Island (39)
South America (1654)
South Carolina (35)
South Dakota (1)
Southern California (2784)
Tennessee (126)
Texas (1148)
United States (28639)
Utah (225)
Virginia (205)
Washington D.C. (80)
Washington State (670)
West Virginia (4)
Wisconsin (83)
There are 851,658 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
Nektar Declares Phase IIb Eczema Win for Rezpeg—But Analysts Unconvinced
Despite Nektar’s share price shooting up as much as 175% on Tuesday, William Blair maintained that “there is an absence of clear differentiation” for rezpegaldesleukin in the atopic dermatitis space.
June 25, 2025
·
2 min read
·
Tristan Manalac
Podcast
FDA Churn Continues, RFK Faces Congress, Obesity Insights at ADA, BIO2025 Recap
Robert F. Kennedy Jr. testified in front of largely combative congresspeople on vaccine policy, his MAHA report and more; the mass leadership exodus at the FDA continues as CDER and CBER shed key staff; Kennedy’s revamped CDC vaccine advisors convene for their first meeting; Novo and Lilly present new data at the American Diabetes Association’s annual meeting; and BioSpace recaps BIO2025.
June 25, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Idorsia launches repurchase offer for its 2025 and 2028 convertible bonds
June 25, 2025
·
6 min read
Press Releases
Press Release: Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation
June 25, 2025
·
6 min read
Press Releases
Novartis announces expiration of Regulus Therapeutics tender offer
June 25, 2025
·
6 min read
Press Releases
Evotec Joins NURTuRE-AKI Consortium to Gain Multi-Omics-Based Molecular Understanding of Acute Kidney Injury
June 25, 2025
·
7 min read
Press Releases
Forte Biosciences Announces Pricing of $75 Million Public Offering
June 25, 2025
·
4 min read
Press Releases
Actimed Therapeutics Enrolls First Patients in Phase 2a PROACT Study Programme to Assess S-pindolol benzoate in Obese Patients During and Post-GLP-1 Agonist Therapy
June 25, 2025
·
4 min read
Press Releases
Essential Pharma strengthens Board with the appointment of Nicola Heffron as Non-Executive Director
June 25, 2025
·
2 min read
Press Releases
Blue Earth Therapeutics: SNMMI Presentation of Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial
June 25, 2025
·
5 min read
1 of 85,166
Next
